Stockscreener 앱 받기
5.96
12.35%
-0.84
시간 외 거래:
6.08
0.12
+2.01%
전일 마감가:
$6.80
열려 있는:
$6.73
하루 거래량:
217.27K
Relative Volume:
2.22
시가총액:
$217.78M
수익:
$18.81M
순이익/손실:
$-38.90M
주가수익비율:
-4.7772
EPS:
-1.2476
순현금흐름:
$-38.83M
1주 성능:
-12.35%
1개월 성능:
-18.80%
6개월 성능:
+10.17%
1년 성능:
+54.01%
1일 변동 폭
$5.91
$6.80
1주일 범위
$5.91
$6.96
52주 변동 폭
$3.86
$8.95
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.96 | 248.47M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | Lake Street | Buy |
| 2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
| 2023-11-28 | 개시 | Stifel | Hold |
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch - Yahoo Finance
Profound Medical to Present at BIG10 Growth Conference - TipRanks
Profound Medical (NASDAQ: PROF) plans one-on-one investor talks at BIG10 conference - Stock Titan
Profound Medical Corp. (PROF) Peer Comparison – Compare with Others - Value Research
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference - Investing News Network
Profound Medical Corp. to Present at Lake Street Capital Markets BIG10 Conference on September 10 - kalkine.ca
Profound Medical Names Richard Fabian as New President - TipRanks
Profound Medical names Richard R. Fabian as President; Mathieu Burtnyk becomes CTO - TradingView
New Profound Medical (PROF) president set for $550,000 salary plus stock awards - Stock Titan
(PROF) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Profound Medical names Richard Fabian as president By Investing.com - Investing.com Australia
Profound Medical Appoints Richard Fabian as President - marketscreener.com
Profound Medical Taps Industry Veteran Richard Fabian as President in Leadership Realignment - tipranks.com
Profound Medical Names Industry Veteran Richard Fabian as President in Leadership Realignment - TipRanks
Profound Medical Appoints Richard Fabian President - marketscreener.com
Profound Medical Corp. Announces Executive Changes - marketscreener.com
Profound Medical Corp. (PROF) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Profound Medical Corp. (PROF) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Profound Medical Stock Falls 2.63%: Can TSX:PRN Overcome Commercialization Challenges and Healthcare Technology Risks? - kalkine.ca
Profound Medical Corp. (TSX:PRN) Gains Momentum as TULSA-PRO Innovation Strengthens Healthcare Technology Outlook - kalkine.ca
Could AI Reshape Canada’s Healthcare Stocks? (TSX:PRN) - Kalkine Media
Profound Medical Corp. Stock Surges 4.46% as Trading Activity Spikes and Market Attention Builds - kalkine.ca
Profound (PROF) Results Versus Estimates: Reported EPS Tops Expectations in the Current Update; Post-Earnings: The Share Price Adds 2.11%Revenue Surprise History - vinanet.vn
Why Did Profound Medical Corp. (TSX:PRN) Stock Suffer a 6.67% Drop on 20 August 2026? - kalkine.ca
Profound Medical Stock Under Pressure as Growth Hopes Meet Execution Risk - kalkine.ca
Profound (PROF) Earnings Report: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Investor Response: The Stock Ends Down 6.07% in the Available RecordRevenue Warning Signal - vinanet.vn
Profound Medical (PROF) Q2 2026 Earnings Call Transcript - AOL.ca
Why Did Profound Medical Corp. (TSX:PRN) Surge 6.09% on 18 August 2026? - kalkine.ca
Why Profound Medical Corp stock surged yesterday - Wealth Awesome
Profound Medical Stock: Record Orders Meet a CFO Shake-Up - kalkine.ca
Profound Medical (TSX:PRN) Captures Focus Amid Developing Healthcare Story - Kalkine Media
Why Profound Medical Corp stock is skyrocketing today - Wealth Awesome
Profound Medical (TSX:PRN): Could The Market Be Seeing More Potential Ahead? - Kalkine Media
Profound Medical Names Matthew Sobczyk as Interim CFO Following Rashed Dewan’s Departure - Kalkine Media
Profound Medical (TSE:PRN) Insider Thomas Michael Tamberrino Buys 3,755 Shares of Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Profound Medical Launches TULSA-PRO Software Upgrade Targeting Up to Six Procedures Per Day - Minichart
Profound Medical Launches Enhanced TULSA-PRO Software Upgrade - TipRanks
Form 8K PROFOUND MEDICAL CORP. For: 17 August By Investing.com - Investing.com Nigeria
Profound Medical Names Interim CFO Amid Leadership Transition - TipRanks
Profound Medical (NASDAQ: PROF) targets higher TULSA throughput - Stock Titan
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’ - marketscreener.com
Some physicians report four TULSA procedures a day—what changes next? - Stock Titan
Profound Medical (PROF) shifts CFO, ex-finance chief stays on as paid adviser - Stock Titan
Profound Medical Announces Management Change - The Manila Times
Profound Medical Corp. Announces CFO Changes - marketscreener.com
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Profound Medical Unveils 'Let's Huddle' Patient Advocacy Program in August 2026 Filing - Kalkine Media
Profound Medical Launches Global Prostate Patient Advocacy Community - TipRanks
Profound Medical (PROF) launches global ‘Let’s Huddle’ prostate patient community - Stock Titan
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.29%
0.75%
자본화:
|
볼륨(24시간):